Nonetheless, psychedelic therapy represents a novel way of approaching mental health treatment that may benefit many people. It will also bring new knowledge regarding molecular bases of mental illness and how they relate to consciousness. Inquiries into the mechanisms of action of psychedelics will ope...
An editorial is presented on the growing interest in using psychedelic drugs for treating various mental health disorders and emphasizes the importance of the therapeutic context and psychotherapy in conjunction with these compounds. It mentions the potential benefits of psychedelic t...
MDMA is a chemical compound that was widely used by psychiatrists in the 1970s and 1980s to treat various mental disorders, including depression and PTSD. One of its main effects is the expansion of the patient's perceptual spectrum, allowing for more effective therapy. Over the years, MDMA ...
their use as a modern mental health therapy started to gain steam in the late 1950s. Hallucinogens like LSDwere showing immense promise in research-based treatmentsfor alcoholism and a litany of mental health disorders, but due to their connection to‘hippy’ culture, politics stepped in to all...
Psilocybin for depression, for major depressive disorder, and also treatment-resistant depression. And then the other one that perhaps I'd just call out right now is MDMA or ecstasy for the treatment of PTSD. And this is a really exciting one because actually this therapy got breakthrough ...
Psychiatric risks for worsened mental health after psychedelic use Background: Resurgent psychedelic research has largely supported the safety and efficacy of psychedelic therapy for the treatment of various psychiatric di... A Marrocu,H Kettner,B Weiss,... - 《Journal of Psychopharmacology》 被引量...
“We still have a huge amount of work to do because these medicines could really, really revolutionize the entire mental health-care field,” said Dr. Michael Verbora, who works as a medical director at the Field Trip Health therapy centre in Toronto. ...
“They have been closely involved in designing the trial protocols for the integration of the drugs and therapy,” said Rands. The company has now initiated a combined phase 1/2a trial to evaluate the effects of an intravenous formulation of its first drug candidate, SPL026, in healthy ...
psychedelic experience can last 8 hours and usually involves two trained therapists. “A potential solution,” explains Madeira, “might be group therapy, allowing therapists to treat multiple patients simultaneously, thereby reducing costs and making the treatment more feasible within public health ...
After a two-decade hiatus in which research on psychedelics was essentially halted, placebo-controlled clinical trials of psychedelic-assisted therapy for mental health conditions have begun to be published. We identified nine randomized, placebo-controlled clinical trials of psychedelic-assisted therapy ...